130 related articles for article (PubMed ID: 9536461)
41. Effect of lamotrigine on the activities of monoamine oxidases A and B in vitro and on monoamine disposition in vivo.
Southam E; Pereira R; Stratton SC; Sargent R; Ford AJ; Butterfield LJ; Wheable JD; Beckett SR; Roe C; Marsden CA; Hagan RM
Eur J Pharmacol; 2005 Sep; 519(3):237-45. PubMed ID: 16129425
[TBL] [Abstract][Full Text] [Related]
42. Design and early clinical evaluation of selective inhibitors of monoamine oxidase.
Palfreyman MG; McDonald IA; Bey P; Schechter PJ; Sjoerdsma A
Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(6):967-87. PubMed ID: 3266532
[TBL] [Abstract][Full Text] [Related]
43. Distribution of the two forms of monoamine oxidase within monoaminergic neurons of the guinea pig brain.
Ross SB
J Neurochem; 1987 Feb; 48(2):609-14. PubMed ID: 3098921
[TBL] [Abstract][Full Text] [Related]
44. Identification of kaempferol as a monoamine oxidase inhibitor and potential Neuroprotectant in extracts of Ginkgo biloba leaves.
Sloley BD; Urichuk LJ; Morley P; Durkin J; Shan JJ; Pang PK; Coutts RT
J Pharm Pharmacol; 2000 Apr; 52(4):451-9. PubMed ID: 10813558
[TBL] [Abstract][Full Text] [Related]
45. [Effect of centrophenoxine, piracetam and aniracetam on the monoamine oxidase activity in different brain structures of rats].
Stancheva SL; Alova LG
Farmakol Toksikol; 1988; 51(3):16-8. PubMed ID: 3137089
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of rat brain monoamine oxidase activities by psoralen and isopsoralen: implications for the treatment of affective disorders.
Kong LD; Tan RX; Woo AY; Cheng CH
Pharmacol Toxicol; 2001 Feb; 88(2):75-80. PubMed ID: 11169165
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of type A monoamine oxidase by methylquinolines and structurally related compounds.
Naoi M; Nagatsu T
J Neurochem; 1988 Apr; 50(4):1105-10. PubMed ID: 3346669
[TBL] [Abstract][Full Text] [Related]
48. The ex vivo effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on rat intra- and extraneuronal monoamine oxidase activity.
Arai Y; Toyoshima Y; Kinemuchi H; Tadano T; Kisara K
Neurosci Lett; 1986 Oct; 70(2):266-71. PubMed ID: 3490638
[TBL] [Abstract][Full Text] [Related]
49. Relation between brain monoamine oxidase (MAO) activity and the firing rate of locus coeruleus neurons.
Oreland L; Engberg G
Naunyn Schmiedebergs Arch Pharmacol; 1986 Jul; 333(3):235-9. PubMed ID: 3762738
[TBL] [Abstract][Full Text] [Related]
50. Use of a monoclonal antibody for comparative studies of monoamine oxidase B in mitochondrial extracts of human brain and peripheral tissues.
Denney RM; Fritz RR; Patel NT; Widen SG; Abell CW
Mol Pharmacol; 1983 Jul; 24(1):60-8. PubMed ID: 6191193
[TBL] [Abstract][Full Text] [Related]
51. Ontogenesis of enzyme systems deaminating different monoamines.
Blatchford D; Holzbauer M
Br J Pharmacol; 1976 Jun; 57(2):279-93. PubMed ID: 938797
[TBL] [Abstract][Full Text] [Related]
52. Developmental lead exposure alters mitochondrial monoamine oxidase and synaptosomal catecholamine levels in rat brain.
Devi CB; Reddy GH; Prasanthi RP; Chetty CS; Reddy GR
Int J Dev Neurosci; 2005 Jun; 23(4):375-81. PubMed ID: 15927761
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of calcium transport by mercury salts in rat cerebellum and cerebral cortex in vitro.
Yallapragada PR; Rajanna S; Fail S; Rajanna B
J Appl Toxicol; 1996; 16(4):325-30. PubMed ID: 8854219
[TBL] [Abstract][Full Text] [Related]
55. Relationship between platelet monoamine oxidase-B (MAO-B) activity and mercury exposure in fish consumers from the Lake St. Pierre region of Que., Canada.
Stamler CJ; Abdelouahab N; Vanier C; Mergler D; Chan HM
Neurotoxicology; 2006 May; 27(3):429-36. PubMed ID: 16494947
[TBL] [Abstract][Full Text] [Related]
56. Effect of Cd, Zn and Hg complexes of barbituric acid and thiouracil on rat brain monoamine oxidase-B (in vitro).
Shaban NZ; Masoud MS; Awad D; Mawlawi MA; Sadek OM
Chem Biol Interact; 2014 Feb; 208():37-46. PubMed ID: 24300193
[TBL] [Abstract][Full Text] [Related]
57. Neurodevelopmental and Metabolomic Responses from Prenatal Coexposure to Perfluorooctanesulfonate (PFOS) and Methylmercury (MeHg) in Sprague-Dawley Rats.
Reardon AJF; Karathra J; Ribbenstedt A; Benskin JP; MacDonald AM; Kinniburgh DW; Hamilton TJ; Fouad K; Martin JW
Chem Res Toxicol; 2019 Aug; 32(8):1656-1669. PubMed ID: 31340646
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of monoamine oxidase selectively in brain monoamine nerves using the bioprecursor (E)-beta-fluoromethylene-m-tyrosine (MDL 72394), a substrate for aromatic L-amino acid decarboxylase.
Palfreyman MG; McDonald IA; Fozard JR; Mely Y; Sleight AJ; Zreika M; Wagner J; Bey P; Lewis PJ
J Neurochem; 1985 Dec; 45(6):1850-60. PubMed ID: 3840523
[TBL] [Abstract][Full Text] [Related]
59. [Effect of L-DOPA on the function of the brain neuromediator systems].
Lovedova EL
Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(7):19-21. PubMed ID: 3188768
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of brain monoamine oxidase activity by the generation of hydroxyl radicals: potential implications in relation to oxidative stress.
Soto-Otero R; Méndez-Alvarez E; Hermida-Ameijeiras A; Sánchez-Sellero I; Cruz-Landeira A; Lamas ML
Life Sci; 2001 Jul; 69(8):879-89. PubMed ID: 11488401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
